Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial.
David J EinsteinMeredith M ReganJulia S StevensDavid F McDermottRavi A MadanPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
What is most important to patients with BCR prostate cancer? Metastasis-free versus treatment-free survival.